255 related articles for article (PubMed ID: 15178365)
1. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.
Overstreet DH; Keeney A; Hogg S
Eur J Pharmacol; 2004 May; 492(2-3):195-201. PubMed ID: 15178365
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
Overstreet DH; Griebel G
Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
Overstreet DH; Griebel G
Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
5. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression.
Overstreet DH; Stemmelin J; Griebel G
Pharmacol Biochem Behav; 2008 Jun; 89(4):623-6. PubMed ID: 18358519
[TBL] [Abstract][Full Text] [Related]
7. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression.
El Khoury A; Gruber SH; Mørk A; Mathé AA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):535-40. PubMed ID: 16414167
[TBL] [Abstract][Full Text] [Related]
8. Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression.
Overstreet DH; Naimoli VM; Griebel G
Pharmacol Biochem Behav; 2010 Aug; 96(2):206-10. PubMed ID: 20470817
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
Tanaka M; Telegdy G
Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
[TBL] [Abstract][Full Text] [Related]
10. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
Bjørnebekk A; Mathé AA; Brené S
Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
[TBL] [Abstract][Full Text] [Related]
11. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
Harro J; Tõnissaar M; Eller M
Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
Yamano M; Yuki H; Yasuda S; Miyata K
J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
Tamburella A; Micale V; Navarria A; Drago F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
[TBL] [Abstract][Full Text] [Related]
14. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
Przegaliński E; Filip M; Frankowska M; Zaniewska M; Papla I
Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?
Nielsen DM
Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764
[TBL] [Abstract][Full Text] [Related]
16. Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test.
Einat H; Belmaker RH; Zangen A; Overstreet DH; Yadid G
Depress Anxiety; 2002; 15(3):148-51. PubMed ID: 12001182
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Nielsen DM; Carey GJ; Gold LH
Eur J Pharmacol; 2004 Sep; 499(1-2):135-46. PubMed ID: 15363960
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats.
Hansson AC; Rimondini R; Heilig M; Mathé AA; Sommer WH
J Psychopharmacol; 2011 Oct; 25(10):1378-87. PubMed ID: 21262856
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
Liebenberg N; Harvey BH; Brand L; Brink CB
Behav Pharmacol; 2010 Sep; 21(5-6):540-7. PubMed ID: 20555254
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]